HYDROXYLATED AND METHOXYLATED CYCLOPENTA [D] PYRIMIDINES AS AKT PROTEIN KINASE INHIBITORS

The present invention provides compounds, including resolved enantiomers, resolved diastereomers, solvates and pharmaceutically acceptable salts thereof, comprising the Formula (I). Also provided are methods of using the compounds of this invention as AKT protein kinase inhibitors and for the treatm...

Full description

Saved in:
Bibliographic Details
Main Authors CHABOT, CHRISTINE, ZHANG, BIRONG, BLAKE, JAMES F, DO, STEVEN, SPENCER, KEITH LEE, LIANG, JUN, WALLACE, ELI M, XIAO, DENGMING, BENCSIK, JOSEF R, XU, RUI, KALLAN, NICHOLAS C, MITCHELL, IAN S, BANKA, ANNA L, SAFINA, BRIAN, SCHLACHTER, STEPHEN T
Format Patent
LanguageEnglish
French
Published 12.09.2017
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The present invention provides compounds, including resolved enantiomers, resolved diastereomers, solvates and pharmaceutically acceptable salts thereof, comprising the Formula (I). Also provided are methods of using the compounds of this invention as AKT protein kinase inhibitors and for the treatment of hyperproliferative diseases such as cancer. La présente invention concerne des composés répondant à la Formule (I), y compris des énantiomères résolus, des diastéréoisomères résolus, des solvates, et leurs sels pharmaceutiquement acceptables. La présente invention concerne également des procédés d'utilisation des composés en tant qu'inhibiteurs de la protéine kinase AKT et pour le traitement de maladies hyperproliférantes telles que le cancer.
AbstractList The present invention provides compounds, including resolved enantiomers, resolved diastereomers, solvates and pharmaceutically acceptable salts thereof, comprising the Formula (I). Also provided are methods of using the compounds of this invention as AKT protein kinase inhibitors and for the treatment of hyperproliferative diseases such as cancer. La présente invention concerne des composés répondant à la Formule (I), y compris des énantiomères résolus, des diastéréoisomères résolus, des solvates, et leurs sels pharmaceutiquement acceptables. La présente invention concerne également des procédés d'utilisation des composés en tant qu'inhibiteurs de la protéine kinase AKT et pour le traitement de maladies hyperproliférantes telles que le cancer.
Author WALLACE, ELI M
SAFINA, BRIAN
ZHANG, BIRONG
DO, STEVEN
BANKA, ANNA L
SCHLACHTER, STEPHEN T
KALLAN, NICHOLAS C
LIANG, JUN
BENCSIK, JOSEF R
XIAO, DENGMING
CHABOT, CHRISTINE
XU, RUI
BLAKE, JAMES F
SPENCER, KEITH LEE
MITCHELL, IAN S
Author_xml – fullname: CHABOT, CHRISTINE
– fullname: ZHANG, BIRONG
– fullname: BLAKE, JAMES F
– fullname: DO, STEVEN
– fullname: SPENCER, KEITH LEE
– fullname: LIANG, JUN
– fullname: WALLACE, ELI M
– fullname: XIAO, DENGMING
– fullname: BENCSIK, JOSEF R
– fullname: XU, RUI
– fullname: KALLAN, NICHOLAS C
– fullname: MITCHELL, IAN S
– fullname: BANKA, ANNA L
– fullname: SAFINA, BRIAN
– fullname: SCHLACHTER, STEPHEN T
BookMark eNqFissKwjAQAHPQg69vcH_AS8XcY7KSpW1Skj00iJQi8SRtof4_ehCvwsDAMGuxGMYhr0SyyQTfpkoxGlDOQI1sf0EnXfkGHSu4mhs0KVBNhhxGUB9KhiZ4RnJQklMRgZylM7EPcSuWj_45593XG7G_IGt7yNPY5Xnq73nIr06rQp6kLAp9_H-8AekAMvA
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate PYRIMIDINES CYCLOPENTA [D] HYDROXYLES ET METHOXYLES UTILISES EN TANT QU'INHIBITEURS DE LA PROTEINE KINASE AKT
ExternalDocumentID CA2656622C
GroupedDBID EVB
ID FETCH-epo_espacenet_CA2656622C3
IEDL.DBID EVB
IngestDate Fri Jul 26 04:30:54 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_CA2656622C3
Notes Application Number: CA20072656622
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170912&DB=EPODOC&CC=CA&NR=2656622C
ParticipantIDs epo_espacenet_CA2656622C
PublicationCentury 2000
PublicationDate 20170912
PublicationDateYYYYMMDD 2017-09-12
PublicationDate_xml – month: 09
  year: 2017
  text: 20170912
  day: 12
PublicationDecade 2010
PublicationYear 2017
RelatedCompanies GENENTECH, INC
ARRAY BIOPHARMA INC
RelatedCompanies_xml – name: ARRAY BIOPHARMA INC
– name: GENENTECH, INC
Score 3.1025255
Snippet The present invention provides compounds, including resolved enantiomers, resolved diastereomers, solvates and pharmaceutically acceptable salts thereof,...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Title HYDROXYLATED AND METHOXYLATED CYCLOPENTA [D] PYRIMIDINES AS AKT PROTEIN KINASE INHIBITORS
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170912&DB=EPODOC&locale=&CC=CA&NR=2656622C
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3dS8MwED_mFPVNpzK_8yB9K842a9eHIl2S0erWlq7KishoSoe-dMNV_Pe9lm36MshDuMCRHPzuI8ndAdxlOk1TdMNVozszVZoZmSo7FsI960krNaXZq9OjR77hvtCnSXfSgI91LkxdJ_SnLo6IiMoQ72Wtrxd_l1i8_lu5vJefSJo_DmKbK6vo-MFE86cpvG-LMOABUxizmaP4ka1VfoumsR3YRSfarLAgXvtVTsriv0EZHMFeiLyK8hgaedGCA7buu9aC_dHquRunK-QtTyBxEx4Fk2TooKohjs_JSMTuhsASNgxC4ccOeePvJEwiVEq86qhBHBzPMQmjIBaeTzBcd8aCeL7r9b04iMancDsQMXNV3ON0I44pc9aH0c-gWcyLvA1klpkGtaiUuo4-kZlbWUdDoRsYTSDCKD2H9jYuF9uXLuGwEqpat0y4gmb59Z1foxEu5U0tv19vuYQW
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3dS8MwED_mFOebTmV-Lg_St-Jsu3Z9KNIlHa3rF12UFZGxlA59qcNV_Pe9lm36MshDuMCRHPzuI8ndAdxlqjafoxsu6_2FIWuZnsmiZyLcs4Ew54YwBnV6dBDq7rP2NO1PG_C-yYWp64T-1MUREVEZ4r2s9fXy7xKL1X8rV_fiA0mfjyNuMWkdHT8YaP4UiQ0tJ45YRCVKLWpLYWIpld-iKHQP9tHBNiosOC_DKidl-d-gjI7hIEZeRXkCjbxoQ4tu-q614TBYP3fjdI281SmkbsqSaJr6NqoaYoeMBA53twSaUj-KnZDb5JW9kThNUCmxqqMGsXGMOYmTiDteSDBctycO8ULXG3o8SiZn0B05nLoy7nG2FceM2pvDqOfQLD6LvANkkRm6ZmpCqCr6REZuZj0Fha7jYRFhmnYBnV1cLncvdaHl8sCf-V44voKjSsBy3T7hGprl13d-gwa5FLe1LH8BzaGHCQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=HYDROXYLATED+AND+METHOXYLATED+CYCLOPENTA+%5BD%5D+PYRIMIDINES+AS+AKT+PROTEIN+KINASE+INHIBITORS&rft.inventor=CHABOT%2C+CHRISTINE&rft.inventor=ZHANG%2C+BIRONG&rft.inventor=BLAKE%2C+JAMES+F&rft.inventor=DO%2C+STEVEN&rft.inventor=SPENCER%2C+KEITH+LEE&rft.inventor=LIANG%2C+JUN&rft.inventor=WALLACE%2C+ELI+M&rft.inventor=XIAO%2C+DENGMING&rft.inventor=BENCSIK%2C+JOSEF+R&rft.inventor=XU%2C+RUI&rft.inventor=KALLAN%2C+NICHOLAS+C&rft.inventor=MITCHELL%2C+IAN+S&rft.inventor=BANKA%2C+ANNA+L&rft.inventor=SAFINA%2C+BRIAN&rft.inventor=SCHLACHTER%2C+STEPHEN+T&rft.date=2017-09-12&rft.externalDBID=C&rft.externalDocID=CA2656622C